US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 1.6350
  • +0.1850+12.76%
Close May 9 16:00 ET
12.96MMarket Cap-817P/E (TTM)

Akari Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-70.98%3.85M
--3.85M
-11.91%7.18M
41.54%13.25M
114.98%8.15M
150.78%16.72M
-33.40%9.36M
-33.40%9.36M
8.71%13.39M
-70.25%3.79M
-Cash and cash equivalents
-70.98%3.85M
--3.85M
-11.91%7.18M
41.54%13.25M
114.98%8.15M
150.78%16.72M
-33.40%9.36M
-33.40%9.36M
8.71%13.39M
-70.25%3.79M
Prepaid assets
-35.70%299K
--299K
-79.59%629.94K
-78.61%465K
204.79%3.09M
108.32%2.39M
642.63%2.17M
642.63%2.17M
-3.38%1.3M
-39.71%1.01M
Other current assets
97.00%197K
--197K
61.99%186.57K
10.74%100K
--115.17K
--325.74K
-60.60%90.3K
-60.60%90.3K
----
----
Total current assets
-68.58%4.34M
--4.34M
-29.55%8M
18.84%13.82M
136.31%11.35M
148.72%19.43M
-20.25%11.63M
-20.25%11.63M
7.52%14.69M
-66.70%4.8M
Non current assets
Goodwill and other intangible assets
-17.65%14K
--14K
-16.27%15.78K
-25.86%17K
-26.24%18.84K
-19.37%21.34K
-15.55%22.93K
-15.55%22.93K
-10.30%23.93K
-3.56%25.55K
-Other intangible assets
-17.65%14K
--14K
-16.27%15.78K
-25.86%17K
-26.24%18.84K
-19.37%21.34K
-15.55%22.93K
-15.55%22.93K
-10.30%23.93K
-3.56%25.55K
Total non current assets
-17.65%14K
--14K
-16.27%15.78K
-25.86%17K
-26.24%18.84K
-19.37%21.34K
-15.55%22.93K
-15.55%22.93K
-10.30%23.93K
-3.56%25.55K
Total assets
-68.52%4.36M
--4.36M
-29.53%8.01M
18.75%13.83M
135.45%11.37M
148.15%19.45M
-20.25%11.65M
-20.25%11.65M
7.48%14.72M
-66.58%4.83M
Liabilities
Current liabilities
Payables
76.45%1.67M
--1.67M
-36.96%1.03M
-47.05%947K
-2.99%1.63M
8.63%3.08M
-47.10%1.79M
-47.10%1.79M
-20.21%1.92M
-23.09%1.69M
-accounts payable
76.45%1.67M
--1.67M
-36.96%1.03M
-47.05%947K
-2.99%1.63M
8.63%3.08M
-47.10%1.79M
-47.10%1.79M
-20.21%1.92M
-23.09%1.69M
Current accrued expenses
-19.92%1.38M
--1.38M
70.29%2.4M
-45.93%1.72M
-9.38%1.41M
128.49%2.45M
73.12%3.18M
73.12%3.18M
46.78%1.43M
-19.81%1.56M
Other current liabilities
-83.05%1.35M
--1.35M
--1.8M
609.46%7.95M
----
----
--1.12M
--1.12M
----
----
Current liabilities
-61.93%4.58M
--4.58M
71.79%5.23M
97.61%12.04M
-6.06%3.05M
41.52%5.52M
16.72%6.09M
16.72%6.09M
-62.02%3.36M
-70.83%3.24M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
-61.93%4.58M
--4.58M
71.79%5.23M
97.61%12.04M
-6.06%3.05M
41.52%5.52M
16.72%6.09M
16.72%6.09M
-62.02%3.36M
-70.83%3.24M
Shareholders'equity
Share capital
77.72%1.32M
--1.32M
70.56%1.01M
56.52%745K
49.68%593.49K
54.26%593.49K
23.72%475.97K
23.72%475.97K
-98.98%475.97K
-99.15%396.5K
-common stock
77.72%1.32M
--1.32M
70.56%1.01M
56.52%745K
49.68%593.49K
54.26%593.49K
23.72%475.97K
23.72%475.97K
-98.98%475.97K
-99.15%396.5K
Retained earnings
-4.60%-227.46M
---227.46M
-4.70%-220.45M
-8.89%-217.45M
-9.40%-210.56M
-8.91%-204.88M
-9.56%-199.71M
-9.56%-199.71M
-25.78%-193.92M
-23.68%-192.47M
Paid-in capital
3.50%226.95M
--226.95M
1.89%223.05M
6.79%219.27M
12.80%218.92M
13.95%218.79M
6.98%205.32M
6.98%205.32M
81.53%205.25M
71.77%194.08M
Gains losses not affecting retained earnings
-34.89%-1.04M
---1.04M
-32.87%-825.88K
-42.52%-771K
-47.96%-621.56K
-67.65%-573.32K
16.53%-540.97K
16.53%-540.97K
27.99%-447.42K
31.98%-420.09K
Total stockholders'equity
-112.79%-229K
---229K
-66.59%2.78M
-67.76%1.79M
424.30%8.33M
253.87%13.93M
-40.81%5.55M
-40.81%5.55M
133.88%11.36M
-52.44%1.59M
Total equity
-112.79%-229K
---229K
-66.59%2.78M
-67.76%1.79M
424.30%8.33M
253.87%13.93M
-40.81%5.55M
-40.81%5.55M
133.88%11.36M
-52.44%1.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(Q2)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -70.98%3.85M--3.85M-11.91%7.18M41.54%13.25M114.98%8.15M150.78%16.72M-33.40%9.36M-33.40%9.36M8.71%13.39M-70.25%3.79M
-Cash and cash equivalents -70.98%3.85M--3.85M-11.91%7.18M41.54%13.25M114.98%8.15M150.78%16.72M-33.40%9.36M-33.40%9.36M8.71%13.39M-70.25%3.79M
Prepaid assets -35.70%299K--299K-79.59%629.94K-78.61%465K204.79%3.09M108.32%2.39M642.63%2.17M642.63%2.17M-3.38%1.3M-39.71%1.01M
Other current assets 97.00%197K--197K61.99%186.57K10.74%100K--115.17K--325.74K-60.60%90.3K-60.60%90.3K--------
Total current assets -68.58%4.34M--4.34M-29.55%8M18.84%13.82M136.31%11.35M148.72%19.43M-20.25%11.63M-20.25%11.63M7.52%14.69M-66.70%4.8M
Non current assets
Goodwill and other intangible assets -17.65%14K--14K-16.27%15.78K-25.86%17K-26.24%18.84K-19.37%21.34K-15.55%22.93K-15.55%22.93K-10.30%23.93K-3.56%25.55K
-Other intangible assets -17.65%14K--14K-16.27%15.78K-25.86%17K-26.24%18.84K-19.37%21.34K-15.55%22.93K-15.55%22.93K-10.30%23.93K-3.56%25.55K
Total non current assets -17.65%14K--14K-16.27%15.78K-25.86%17K-26.24%18.84K-19.37%21.34K-15.55%22.93K-15.55%22.93K-10.30%23.93K-3.56%25.55K
Total assets -68.52%4.36M--4.36M-29.53%8.01M18.75%13.83M135.45%11.37M148.15%19.45M-20.25%11.65M-20.25%11.65M7.48%14.72M-66.58%4.83M
Liabilities
Current liabilities
Payables 76.45%1.67M--1.67M-36.96%1.03M-47.05%947K-2.99%1.63M8.63%3.08M-47.10%1.79M-47.10%1.79M-20.21%1.92M-23.09%1.69M
-accounts payable 76.45%1.67M--1.67M-36.96%1.03M-47.05%947K-2.99%1.63M8.63%3.08M-47.10%1.79M-47.10%1.79M-20.21%1.92M-23.09%1.69M
Current accrued expenses -19.92%1.38M--1.38M70.29%2.4M-45.93%1.72M-9.38%1.41M128.49%2.45M73.12%3.18M73.12%3.18M46.78%1.43M-19.81%1.56M
Other current liabilities -83.05%1.35M--1.35M--1.8M609.46%7.95M----------1.12M--1.12M--------
Current liabilities -61.93%4.58M--4.58M71.79%5.23M97.61%12.04M-6.06%3.05M41.52%5.52M16.72%6.09M16.72%6.09M-62.02%3.36M-70.83%3.24M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities -61.93%4.58M--4.58M71.79%5.23M97.61%12.04M-6.06%3.05M41.52%5.52M16.72%6.09M16.72%6.09M-62.02%3.36M-70.83%3.24M
Shareholders'equity
Share capital 77.72%1.32M--1.32M70.56%1.01M56.52%745K49.68%593.49K54.26%593.49K23.72%475.97K23.72%475.97K-98.98%475.97K-99.15%396.5K
-common stock 77.72%1.32M--1.32M70.56%1.01M56.52%745K49.68%593.49K54.26%593.49K23.72%475.97K23.72%475.97K-98.98%475.97K-99.15%396.5K
Retained earnings -4.60%-227.46M---227.46M-4.70%-220.45M-8.89%-217.45M-9.40%-210.56M-8.91%-204.88M-9.56%-199.71M-9.56%-199.71M-25.78%-193.92M-23.68%-192.47M
Paid-in capital 3.50%226.95M--226.95M1.89%223.05M6.79%219.27M12.80%218.92M13.95%218.79M6.98%205.32M6.98%205.32M81.53%205.25M71.77%194.08M
Gains losses not affecting retained earnings -34.89%-1.04M---1.04M-32.87%-825.88K-42.52%-771K-47.96%-621.56K-67.65%-573.32K16.53%-540.97K16.53%-540.97K27.99%-447.42K31.98%-420.09K
Total stockholders'equity -112.79%-229K---229K-66.59%2.78M-67.76%1.79M424.30%8.33M253.87%13.93M-40.81%5.55M-40.81%5.55M133.88%11.36M-52.44%1.59M
Total equity -112.79%-229K---229K-66.59%2.78M-67.76%1.79M424.30%8.33M253.87%13.93M-40.81%5.55M-40.81%5.55M133.88%11.36M-52.44%1.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg